UPDATED 20.02.2014 13:01

Organised cervical cancer screening programme in the Helsinki and Uusimaa health care district in Finland in the invitation year 2005. Numbers and percentage distribution of primary screening test results, referrals for further examinations, and histological diagnosis of the cervix uteri.

Screening Screened Referral Histological diagnosis
test     Invasive
carcinoma
Microinvasive
carcinoma
Carcinoma
in situ
Dysplasia
gravis
Dysplasia
moderata
Dysplasia
levis
Other or
normal
  n n % n % n % n % n % n % n % n %
Pap test1 45039 591 1.31 3 0.01 1 0.00 9 0.02 31 0.07 91 0.20 63 0.14 393 0.87
I 41675 1 - - - - - - - - - - - - - 1 -
II 2726 51 0.11 1 - - - - - - - - - 3 0.01 47 0.10
III 512 512 1.14 1 - - - 6 0.01 22 0.05 86 0.19 58 0.13 339 0.75
IV 26 26 0.06 1 - 1 - 2 - 9 0.02 5 0.01 2 - 6 0.01
V 1 1 - - - - - 1 - - - - - - - - -
Inadequate 99 - - - - - - - - - - - - - - - -
Unknown - - - - - - - - - - - - - - - - -
HPV test 16249 237 1.46 1 0.01 1 0.01 - - 21 0.13 56 0.34 31 0.19 127 0.78
Negative1 14683 10 0.06 - - - - - - - - - - - - 10 0.06
Positive2 1566 227 1.40 1 0.01 1 0.01 - - 21 0.13 56 0.34 31 0.19 117 0.72
Total 61288 828 1.35 4 0.01 2 0.00 9 0.01 52 0.08 147 0.24 94 0.15 520 0.85

1 Women with Papanicolaou class I or II negative HPV test are not referred for further examinations unless repeated cytology or other results are suggestive of cancer.
2 Women whose HPV test is positive are referred for further examinations on the basis of cytology or a repeatedly positive result.